Direxion NASDAQ 100 Equal Weighted Index Shares vs Boston Beer Company Inc — how do they compare? Direxion NASDAQ 100 Equal Weighted Index Shares trades at $121.19 (market cap $1.47B), while Boston Beer Company Inc trades at $171.2 (market cap $1.73B). The key difference: Boston Beer Company Inc is the larger of the two by market cap, and Direxion NASDAQ 100 Equal Weighted Index Shares is trading nearer its 52-week high, Boston Beer Company Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Direxion NASDAQ 100 Equal Weighted Index Shares for 47 Days and Boston Beer Company Inc for 59 Days on average.
| QQQE | SAM | |
|---|---|---|
Market Cap | $1.47B | $1.73B |
Volume | 181,648 | 196,621 |
Sector | Broad Market / Factor | Consumer Staples |
52-Week High | $124.69 | $260.05 |
52-Week Low | $96.06 | $161.08 |
Typical Hold Time | 47 Days | 59 Days |
Enterprise Value | — | $1.50B |
Signals from Pluang's Aura AI — not financial advice
QQQE (Direxion NASDAQ-100 Equal Weighted Index ETF) trades at $121.89, down 0.89% on the day. The ETF maintains a bullish technical outlook with strong moving average signals while oscillators show neutral momentum. Recent analysis highlights QQQE's advantage over traditional NASDAQ-100 ETFs due to its equal-weight approach, reducing technology concentration from 60% to 45% while maintaining exposure to large-cap growth stocks.
The equal-weight methodology provides diversification benefits amid tech sector volatility. Key risks include market concentration in growth stocks and broader market sentiment shifts. Recent analyst commentary suggests tactical opportunities in equal-weight strategies for the coming year, though investors should monitor sector rotation trends.
Boston Beer Company (SAM) trades at $168.16, down 1.3% with a neutral technical outlook. The stock shows mixed fundamentals with a P/E of 22.66 and P/S of 0.92, but negative net income margin of -3.64% and ROE of -8.61%. Recent earnings missed expectations in Q1 and Q2 2026, though Q4 2025 beat estimates. The company maintains positive operating cash flow of $270M in 2025 while expanding brand innovation with new product launches and marketing initiatives.
SAM faces headwinds from volume declines and cost pressures, but brand investments and new product categories offer growth potential. Analyst consensus is cautious with 72% hold ratings, though the $204.44 price target suggests 22% upside. Key risks include competitive pressures and shifting consumer preferences in the alcoholic beverage market.
Trailing returns across standard periods
QQQE is an ETF that seeks to track the performance of the NASDAQ-100 Equal Weighted Index. Unlike traditional market-capitalization-weighted indexes, this fund assigns equal weight to each of the 100 non-financial companies in the NASDAQ-100 and rebalances quarterly. This equal-weighting scheme reduces concentration risk in the largest technology companies and increases the fund's exposure to smaller-cap and mid-cap companies within the index, providing a differentiated growth profile.
Read more on QQQE →Boston Beer is a leader in U.S. high-end malt beverages and adjacent categories, with strong positions in craft beer, hard cider, and hard seltzer. The firm sells an array of flavor variants and package sizes, predominantly centered around four priority brands: Samuel Adams, Angry Orchard, Twisted Tea, and Truly Hard Seltzer. Its drinks are produced in both company-owned breweries as well as through third-party contract arrangements, and while the company primarily goes to market through independent wholesalers (as mandated by law), it operates a fairly large salesforce to induce demand across the value chain (distributors, retailers, and drinkers). The preponderance of revenue is generated domestically.
Read more on SAM →